| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $528.3M | +32.3% |
| Cost of Revenue | $52.9M | +41.8% |
| Gross Profit | $475.4M | +31.3% |
| R&D Expense | $109.4M | -28.2% |
| SG&A Expense | $323.4M | +17.5% |
| Operating Income | $24.9M | +132.2% |
| Pre-tax Income | -$28.8M | +80.8% |
| Income Tax | $27.4M | +1744.2% |
| Net Income | -$56.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $213.8M | -13.5% |
| Short-term Investments | $36.2M | -7.7% |
| Accounts Receivable | $101.1M | +15.4% |
| Inventory | $118.8M | +99.0% |
| Current Assets | $504.7M | +4.5% |
| Total Assets | $785.0M | +0.9% |
| Current Liabilities | $148.7M | -11.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.9M | +50.9% |
| Capital Expenditures | $3.6M | -52.2% |
| Investing Cash Flow | -$560K | -100.6% |
| Financing Cash Flow | $5.1M | -91.7% |
| Free Cash Flow | -$37.4M | +51.1% |
| +63.0% |
| EPS (Basic) | -$0.18 | +64.7% |
| EPS (Diluted) | -$0.18 | +64.7% |
| Long-term Debt |
| $390.1M |
| +0.6% |
| Total Liabilities | $591.0M | -4.3% |
| Stockholders' Equity | $194.0M | +21.1% |